Delivery Order SPE2DB20D6036-SPE2DB24FC8PE
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,493.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a medical product. The contract has an ultimate completion date of March 20, 2025 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award is a delivery order worth $1,845.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,785,500 milliliters of medroxyprogesterone 150 mg/mL, a prescription medication. The contract has a firm fixed price and has an ultimate completion date of September 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,019.62 firm fixed price contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has a completion date of January 22, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution...
This federal contract award, valued at $1,192.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $15,045.76 firm fixed-price delivery order is for the supply of Medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has a completion date of September 12, 2024 and is not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies and...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.28, is for the procurement of Medroxyprogesterone 150 mg/ml. It is a firm-fixed-price contract with a completion date of December 12, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.14 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.38 contract is for the delivery of 4,568,119,737 milliliters of the medication Medroxyprogesterone 150 mg/ml. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award is for the delivery of Medroxyprogesterone 150 mg/mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,177.00, is a firm fixed-price delivery order with a performance period ending on May 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,177.04, is for the delivery of medroxyprogesterone 150 mg/ml, a medication used for various medical conditions. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 5, 2021. Amerisourcebergen Drug Corp is a subsidiary of the...